Back
Sarepta Therapeutics Vs. Adobe Industry Stock Comparison
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
127.17
Seasonality Move:
0.19%
Buy
56
ADBE
Adobe
Last Price:
522.21
Seasonality Move:
7.73%
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $127.10. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Adobe (ADBE)
is a Buy
Is Adobe a Buy, Sell or Hold?
- The current Adobe [ADBE] share price is $526.44. The Score for ADBE is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ADBE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $127.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.72 | Sell |
| Relative Strength Index (14 RSI): | 38.7 | Sell |
| Chaikin Money Flow: | -11607 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (127.06 - 139.4) | Sell |
| Bollinger Bands (100): | (124.44 - 147.62) | Sell |
ADBE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.48 | Sell |
| Relative Strength Index (14 RSI): | 41.05 | Sell |
| Chaikin Money Flow: | 2750166 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (537.65 - 577.87) | Sell |
| Bollinger Bands (100): | (482.99 - 564.01) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.94 | Buy |
| 20-day SMA: | 132.14 | Sell |
| 50-day SMA: | 138.1 | Sell |
| 200-day SMA: | 126.4 | Buy |
| 8-day EMA: | 126.81 | Buy |
| 20-day EMA: | 130.43 | Sell |
| 50-day EMA: | 134.6 | Sell |
| 200-day EMA: | 128.85 | Sell |
ADBE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 543.72 | Sell |
| 20-day SMA: | 557.27 | Sell |
| 50-day SMA: | 549.63 | Sell |
| 200-day SMA: | 541.97 | Sell |
| 8-day EMA: | 535.9 | Sell |
| 20-day EMA: | 548.26 | Sell |
| 50-day EMA: | 545.65 | Sell |
| 200-day EMA: | 530.15 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Adobe Earnings Growth & ADBE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.56 per share, an increase next quarter of $0.67 per share, an increase this year of $2.34 per share, and an increase next year of $2.28 per share.
Sarepta Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adobe Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||